Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Making Pharmaceuticals, Distributing Pharmaceuticals and Making Nutraceuticals 2026
Friday, January 16, 2026Making Pharmaceuticals Distributing Pharmaceuticals and Making Nutraceuticals are colocated freetoattend events providing professionals from across the pharmaceutical and nutraceutical industries
Vetter Reaches Key Launch Milestones for the V-OVS® next Tamper-Evident Syringe Closure System
Friday, January 16, 2026Vetter a globally operating Contract Development and Manufacturing Organization CDMO has completed several important steps in the ongoing development and upcoming launch of VOVS next
Boehringer Ingelheim advances potential first-in-class IL-11 inhibitor to Phase II Clinical Research in Idiopathic Pulmonary Fibrosis
Wednesday, January 14, 2026Boehringer Ingelheim today announced the start of a Phase IIa clinical trial evaluating BI a novel monoclonal antibody targeting interleukin IL in patients with idiopathic pulmonary fibrosis IPF
Novotech Appoints Anand Tharmaratnam as New CEO
Tuesday, January 13, 2026Novotech a globally recognized fullservice biotech clinical research organization CRO is pleased to announce the appointment of Dr Anand Tharmaratnam as its new Chief Executive Officer
SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer's Disease
Tuesday, January 13, 2026SciNeuro Pharmaceuticals today announced it has entered into a worldwide licensing and collaboration agreement with Novartis Pharma AG to advance SciNeuros novel amyloid beta targeted antibody program for the treatment of Alzheimers Disease
CARsgen and Dispatch Bio Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-cel in Solid Tumors
Tuesday, January 13, 2026CARsgen Therapeutics Holdings Limited a company focused on developing innovative CAR Tcell therapies and Dispatch Bio a biotech company engineering a universal treatment across solid tumors leveraging its firstinclass Flare platform
DISCO Pharmaceuticals Enters License Agreement to Advance Novel Cancer Surfaceome Targeted Therapies
Thursday, January 08, 2026DISCO Pharmaceuticals DISCO today announced an exclusive license agreement with Amgen to advance novel therapeutic candidates addressing a target that was mapped on the surface of a cancer cell by DISCOs proprietary platform
Arbele Receives FDA Orphan Drug Designation for ARB1002, an Anti-CDH17 Antibody-Drug Conjugate for the Treatment of Pancreatic Cancer
Thursday, January 08, 2026Arbele a biotechnology company focused on developing innovative targeted cancer therapies today announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation ODD to ARB
Exdensur (depemokimab) approved in Japan for severe asthma and chronic rhinosinusitis with nasal polyps
Wednesday, January 07, 2026GSK plc today announced the approval of Exdensur depemokimab by Japans Ministry of Health Labour and Welfare MHLW as a treatment for bronchial asthma limited to severe or refractory patients whose asthma symptoms
Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treatment Outcomes
Wednesday, January 07, 2026Thermo Fisher Scientific Inc the world leader in serving science today announced the enrollment of the first patient in the new PPD CorEvitas Obesity Registry This prospective observational registry will generate realworld evidence
